Predictive models for mutations in mismatch repair genes: Implication for genetic counseling in developing countries

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Monteiro Santos, Erika M ^a   Valentin, Mev D ^a   Carneiro, Felipe ^a   de Oliveira, Ligia P ^a   de Oliveira Ferreira, Fabio ^a   Junior, Samuel A ^a   Nakagawa, Wilson T ^a   Gomy, Israel ^a,b   de Faria Ferraz, Victor E ^b   da Silva Junior, Wilson A ^b   Carraro, Dirce M ^a   Rossi, Benedito M ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARNETSON MODEL; BLOOD SAMPLING; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; GENE; GENE MUTATION; GENETIC COUNSELING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR GENE; MLH1 GENE; MMRPRO MODEL; MSH2 GENE; MSH6 GENE; MUTATIONAL ANALYSIS; MYRIAD MODEL; NONBIOLOGICAL MODEL; NUCLEOTIDE SEQUENCE; PREDICTION; PREDICTION OF MUTATIONS IN MLH1 AND MSH2 MODEL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; WIJNEN MODEL;

ADULT; AGED; BRAZIL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DEVELOPING COUNTRIES; DNA MISMATCH REPAIR; FEMALE; GENETIC COUNSELING; GERM-LINE MUTATION; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84858148591     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-64     Document Type: Article

References (44)

1. da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer 2010, 9(4):563-70. 10.1007/s10689-010-9373-2, 20697958.
2. Lynch HT, Ens J, Lynch JF, Watson P. Tumor variation in three extended Lynch syndrome II kindreds. Am J Gastroenterol 1988, 83(7):741-747.
3. Lynch HT, Lynch JF. The Lynch syndromes. Curr Opin Oncol 1993, 5(4):687-696. 10.1097/00001622-199307000-00013, 8364086.
4. Lin KM, Shashidharan M, Ternent CA, et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary non- polyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998, 41(4):428-433. 10.1007/BF02235755, 9559626.
5. Valentin MD, Silva FC, Santos EM, Lisboa BG, de Oliveira LP, Ferreira FD, Gomy I, Nakagawa WT, Aguiar Junior S, Redal M, Vaccaro C, Valle AD, Sarroca C, Carraro DM, Rossi BM. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 2011,
6. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991, 34(5):424-5. 10.1007/BF02053699, 2022152.
7. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453-6. 10.1016/S0016-5085(99)70510-X, 10348829.
8. Altman DG, Bland JM. Diagnotic tests 1: sensivity and specitivity. BMJ 1994, 308:1552. 10.1136/bmj.308.6943.1552, 2540489, 8019315.
9. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997, 89:1758-62. 10.1093/jnci/89.23.1758, 9392616.
10. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261-8. 10.1093/jnci/djh034, 2933058, 14970275.
11. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997;113(4):1146-58. de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005, 4(3):233-7. 10.1007/s10689-004-5811-3, 16136383.
12. de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005, 4(3):233-7. 10.1007/s10689-004-5811-3, 16136383.
13. Ou J, Niessen RC, Lützen A, et al. Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat 2007, 28:1047-54. 10.1002/humu.20580, 17594722.
14. Ou J, Niessen RC, Vonk J, et al. A Database to support the interpretation of human mismatch repair gene variants. Hum Mutat 2008, 29:1337-41. 10.1002/humu.20907, 18951442.
15. Couch FJ, Rasmussen LJ, Hofstra R, et al. Assesment of functional effects of unclassified genetic variants. Hum Mutat 2008, 29:1314-26. 10.1002/humu.20899, 2771414, 18951449.
16. Baudi F, Fersini G, Lavecchia A, et al. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. Cancer Lett 2005, 223:285-91. 10.1016/j.canlet.2004.09.051, 15896463.
17. Johnson MM, Houck J, Chen C. Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1326-9. 10.1158/1055-9965.EPI-04-0815, 15894696.
18. Euhus D, Smith K, Robinson L, Stucky A, Olopade O, Cummings S, Garber J, Chittenden A, Mills G, Rieger P, et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 2002, 94(11):844-51. 10.1093/jnci/94.11.844, 12048272.
19. Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005, 97(10):715-23. 10.1093/jnci/dji128, 15900041.
20. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber S, Euhus D, Kinzler K, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006, 296(12):1479-1487. 10.1001/jama.296.12.1479, 2538673, 17003396.
21. Barnetson R, Tenesa A, Farrington S, Nicholl I, Cetnarskyj R, Porteous M, Campbell H, Dunlop M. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006, 354(26):2751-2763. model available at http://hnpccpredict.hgu.mrc.ac.uk/., 10.1056/NEJMoa053493, 16807412.
22. Wijnen J, Vasen H, Khan P, Zwinderman A, van der Klift H, Mulder A, Tops C, Møller P, Fodde R. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998, 339(8):511-518. 10.1056/NEJM199808203390804, 9709044.
23. Balmaña J, Stockwell D, Steyerberg E, Stoffel E, Deffenbaugh A, Reid J, Ward B, Scholl T, Hendrickson B, Tazelaar J, et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006, 296(12):1469-1478. 10.1001/jama.296.12.1469, 17003395.
24. Mutation Prevalence Tables Available at [http://www.myriadtests.com/index.php?page_id=250&]. Accessed at 2010.
25. Green R, Parfrey P, Woods M, Younghusband H. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst 2009, 101(5):331-340. 10.1093/jnci/djn499, 19244167.
26. Balaguer F, Balmaña J, Castellví-Bel S, Steyerberg E, Andreu M, Llor X, Jover R, Syngal S, Castells A. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 2008, 134(1):39-46. 10.1053/j.gastro.2007.10.042, 2542581, 18061181.
27. Balmaña J, Balaguer F, Castellví-Bel S, Steyerberg E, Andreu M, Llor X, Jover R, Castells A, Syngal S. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 2008, 45(9):557-563. model available at http://www.dana-farber.org/pat/cancer/gastrointestinal/crc-calculator/new-calculator.asp., 10.1136/jmg.2008.059311, 18603628.
28. Monzon J, Cremin C, Armstrong L, Nuk J, Young S, Horsman D, Garbutt K, Bajdik C, Gill S. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Int J Cancer 2010, 126(4):930-939.
29. Ramsoekh D, van Leerdam M, Wagner A, Kuipers E, Steyerberg E. Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting. J Med Genet 2009, 46(11):745-751. 10.1136/jmg.2009.066589, 19541685.
30. Pouchet C, Wong N, Chong G, Sheehan M, Schneider G, Rosen-Sheidley B, Foulkes W, Tischkowitz M. A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. Ann Oncol 2009, 20(4):681-688. 10.1093/annonc/mdn686, 19164453.
31. BRAZIL. Brazillian Institute of Geography and Statistics. [Características étnico-raciais da população: um estudo de categorias de cor e raça]. Rio de Janeiro, IBGE 2008,
32. Fawcett T. An introduction to ROC analysis. Patt Recog Lett 2006, 27:861-874.
33. Hanley J, McNeil B. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 1982, 143:29-36.
34. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-45. 10.2307/2531595, 3203132.
35. BRAZIL. Ministry of Health. [Rede operacional de cancer familial]. Rio de Janeiro, Instituto Nacional do Câncer 2009,
36. Koehler-Santos P, Izetti P, Abud J, Pitroski CE, Cossio SL, Camey SA, Tarta C, Damin DC, Contu PC, Rosito MA, Ashton-Prolla P, Prolla JC. Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic. World J Gastroenterol 2011, 17:766-73. 10.3748/wjg.v17.i6.766, 3042655, 21390147.
37. Alonso-Espinaco V, Giráldez MD, Trujillo C, van der Klift H, Muñoz J, Balaguer F, Ocaña T, Madrigal I, Jones AM, Echeverry MM, Velez A, Tomlinson I, Milà M, Wijnen J, Carvajal-Carmona L, Castells A, Castellví-Bel S. Novel MLH1 duplication identified in Colombian families with Lynch syndrome. Genet Med 2011, 13:155-60. 10.1097/GIM.0b013e318202e10b, 21233718.
38. Alvarez K, Hurtado C, Hevia MA, Wielandt AM, de la Fuente M, Church J, Carvallo P, López-Köstner F. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome. Dis Colon Rectum 2010, 53:450-9. 10.1007/DCR.0b013e3181d0c114, 20305446.
39. Gomez LC, Marzese DM, Adi J, Bertani D, Ibarra J, Mol B, Vos IJ, De Marchi G, Roqué M. MLPA mutation detection in Argentine HNPCC and FAP families. Fam Cancer 2009, 8:67-73. 10.1007/s10689-008-9200-1, 18615272.
40. Vaccaro CA, Bonadeo F, Roverano AV, Peltomaki P, Bala S, Renkonen E, Redal MA, Mocetti E, Mullen E, Ojea-Quintana G, Benati ML, Rivello HG, Clark MB, Lynch JF, Lynch HT. Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register. Dis Colon Rectum 2007, 50:1604-11. 10.1007/s10350-007-9037-y, 17846840.
41. Giraldo A, Gómez A, Salguero G, García H, Aristizábal F, Gutiérrez O, Angel LA, Padrón J, Martínez C, Martínez H, Malaver O, Flórez L, Barvo R. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)-description of four novel mutations. Fam Cancer 2005, 4:285-90. 10.1007/s10689-005-4523-7, 16341804.
42. Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K, . Genetics, genomics, and cancer risk assessment State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin 2011, 61:327-59. Genetics, genomics, and cancer risk assessment.
43. Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res 2009, 42:870-6. 10.1590/S0100-879X2009005000026, 19738982.
44. Lins TC, Vieira RG, Abreu BS, Grattapaglia D, Pereira RW. Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. Am J Hum Biol 2010, 22:187-92.